Actionable news
0
All posts from Actionable news
Actionable news in AZN: ASTRAZENECA PLC,

AstraZeneca (AZN) Stock Down Ahead of Earnings Results

NEW YORK (TheStreet) -- AstraZeneca (AZN - Get Report) will report its 2015 third quarter earnings results before the market open on Thursday.

Analysts surveyed by Thomson Reuters estimate that AstraZeneca will report earnings of 77 cents per share on revenue of $5.9 billion.

The London-based biopharmaceutical company reported earnings of $1.05 per share on revenue of $6.54 billion for the third quarter of 2014.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks with serious upside potential in the next 12-months. Learn more.

Earlier this month, the FDA rejected the company's proposal for a diabetes drug combination.

AstraZeneca stock was down by 0.77% to $32.06 in mid-afternoon trading on Wednesday.

Separately, TheStreet Ratings team rates ASTRAZENECA PLC as a Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:

We rate ASTRAZENECA PLC (AZN) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing...


More